Association of the genetic polymorphisms of metabolizing enzymes, transporters, target receptors and their interactions with treatment response to olanzapine in chinese han schizophrenia patients.

Abstract

Olanzapine is an atypical antipsychotic drug that has been increasingly used for treatment in schizophrenia. It has been observed that olanzapine responses in schizophrenia patients vary individually, but the reason has not been elucidated. In the study, we aimed to comprehensively explore the relationships between olanzapine responses and genetic polymorphisms of drug metabolizing enzymes, transporters and target receptors, and so as to interpret the reason of good and poor responses of olanzapine. A total of 241 Chinese Han paranoid schizophrenia who treated with olanzapine alone for 4 weeks were recruited. The positive and negative symptom scale (PANSS) was used to evaluate the efficacy of olanzapine. The genetic polymorphisms were detected by improved multiple ligase detection reaction (iMLDR). Multivariate logistic regression analysis suggested that the genetic polymorphisms of CYP1A2 rs762551, UGT1A4 rs2011425, ABCB1 rs1045642, DRD2 rs1799732 and rs1799978, 5-HTR2A rs6311 were significantly associated with olanzapine response. Multifactor dimensionality reduction (MDR) analysis showed that there was a negative interaction between CYP1A2 rs762551, ABCB1 rs1045642, DRD2 rs1799978, 5-HTR2A rs6311 and the interaction model was the optimal model. Our findings could partially explain the different olanzapine outcome and provided evidence for clarifying the predictive indicators of olanzapine response in further.

• Authors: Pan Yan, Mingfen Song, Bing Gao, Shuqi Wang, Shengdong Wang, Jing Li, Haihong Fang, Chengpeng Wang, Jianfei Shi
• Journal: Psychiatry research (Psychiatry Res) Vol. 293 Pg. 113470 (11 2020) ISSN: 1872-7123 [Electronic] Ireland
• PMID: 32992097 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2020 Elsevier B.V. All rights reserved.

Chemical References

• Antipsychotic Agents
• Membrane Transport Proteins
• CYP1A2 protein, human
• Cytochrome P-450 CYP1A2
• Olanzapine

Topics

• Adult
• Antipsychotic Agents (therapeutic use)
• Asian People (genetics)
• Cytochrome P-450 CYP1A2 (genetics)
• Female
• Genotype
• Humans
• Male
• Membrane Transport Proteins (genetics)
• Middle Aged
• Olanzapine (therapeutic use)
• Polymorphism, Genetic
• Schizophrenia, Paranoid (drug therapy, ethnology, genetics)
• Treatment Outcome